Session Information
2008 BIO International Convention
Click here to go to the previous page
Moore's Law for Biomanufacturing: Innovation in a Maturing Biologicals Industry
Track : Manufacturing
Program Code: 1156
Date: Thursday, June 19, 2008
Time: 4:00 PM to 5:30 PM  EST
Location: 29B
CHAIR :
Michael Kowolenko, PhD, Senior Vice President, Biotech Operating Unit, TO&PS , Wyeth Pharmaceuticals, Inc.
SPEAKER (S):
Edward Arcuri, PhD, Chief Operations Officer , VaxInnate Corporation
Parrish Galliher, MS, President, Founder & CTO , Xcellerex, Inc
Robert Tenerowicz, MBA, VP, Operations , XOMA, Ltd
Description
"Biotherapeutics are today the fastest-growing segment of the pharmaceutical industry, with more than 200 marketed
products and hundreds more in development. This growth has created new demands for innovation in manufacturing: increased production efficiency, improved flexibility to make multiple products, reduced product development lead time and higher returns on manufacturing investment. This panel will examine a range of innovative biomanufacturing
solutions, including new process development approaches, new expression systems and single-use disposable biomanufacturing systems."

Objective1:Describe ongoing innovation in the manufacture of biologicals.

Objective2:Explain the role of manufacturing innovation in driving and responding to growth in the sector.

Objective3:Provide real-world examples of how biomanufacturers are making better biologicals and improving industry ROIs.


Streaming Audio with
PowerPoint Slides
(Code: 1156)
  
This session is a part of: